Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

SHE:300573 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	505.16	370.12	480.42	515.45	686.36	37.22
Cash & Short-Term Investments	505.16	370.12	480.42	515.45	686.36	37.22
Cash Growth	-11.04%	-22.96%	-6.80%	-24.90%	1744.12%	-25.51%
Accounts Receivable	279.42	277.93	252.1	194.96	170.62	158.23
Other Receivables	2.03	3.37	3.93	4.62	5.84	3.15
Receivables	281.45	281.3	256.03	199.58	176.46	161.37
Inventory	166.08	153.6	136.03	122.27	92.33	68.31
Other Current Assets	10.86	24.9	32.71	27.87	29.27	27.32
Total Current Assets	963.56	829.92	905.19	865.17	984.42	294.22
Property, Plant & Equipment	1,037	992.22	837.35	695.92	548.6	527.9
Long-Term Investments	10	10	-	-	-	-
Other Intangible Assets	150	134.57	78.29	27.66	22.83	23.83
Long-Term Deferred Tax Assets	26.16	22.5	38.57	23.77	30.45	33.87
Long-Term Deferred Charges	67.31	64.44	118.76	105.03	60.77	28.22
Other Long-Term Assets	42.78	74	45.68	65.39	39.78	57.67
Total Assets	2,297	2,128	2,024	1,783	1,687	965.7
Accounts Payable	23.07	17.73	17.57	19.46	13.31	6.67
Accrued Expenses	75.6	178.33	125.36	103.97	108.91	91.74
Short-Term Debt	180.15	200.17	70.06	-	100	80
Current Portion of Leases	8.62	6.28	6.87	7.12	4.18	-
Current Income Taxes Payable	62.48	22.84	5.74	-	11.69	-
Current Unearned Revenue	2.93	3.46	6.76	2.01	6.11	5.11
Other Current Liabilities	128.5	32.67	27.76	19.89	22.63	28.98
Total Current Liabilities	481.34	461.48	260.12	152.45	266.83	212.49
Long-Term Leases	9.2	8.86	2.22	6.69	7.1	-
Long-Term Unearned Revenue	62.86	64.13	71.58	71.5	68.42	59.15
Total Liabilities	553.4	534.48	333.92	230.63	342.35	271.64
Common Stock	175.25	175.25	124.59	88.56	88.1	82.37
Additional Paid-In Capital	870.71	866.51	891.01	852.36	782.68	288.16
Retained Earnings	697.3	551.4	674.32	611.4	479	327.11
Treasury Stock	-	-	-	-	-5.28	-13.26
Comprehensive Income & Other	-	-	-	-	-	-2.2
Total Common Equity	1,743	1,593	1,690	1,552	1,344	682.19
Minority Interest	-	-	-	-	-	11.87
Shareholders' Equity	1,743	1,593	1,690	1,552	1,344	694.06
Total Liabilities & Equity	2,297	2,128	2,024	1,783	1,687	965.7
Total Debt	197.97	215.31	79.15	13.81	111.28	80
Net Cash (Debt)	307.19	154.81	401.27	501.64	575.08	-42.78
Net Cash Growth	-32.93%	-61.42%	-20.01%	-12.77%	-	-
Net Cash Per Share	1.75	0.88	2.31	2.91	3.59	-0.27
Filing Date Shares Outstanding	175.25	175.25	174.42	173.57	172.67	161.44
Total Common Shares Outstanding	175.25	175.25	174.42	173.57	172.67	161.44
Working Capital	482.21	368.44	645.07	712.72	717.59	81.72
Book Value Per Share	9.95	9.09	9.69	8.94	7.79	4.23
Tangible Book Value	1,593	1,459	1,612	1,525	1,322	658.36
Tangible Book Value Per Share	9.09	8.32	9.24	8.78	7.65	4.08
Buildings	-	517.5	476.93	470.69	350.19	347.48
Machinery	-	759.99	711.75	534.35	481.36	438.86
Construction In Progress	-	196.85	106.16	70.12	34.94	22.31

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.